Clinical Trial Update: GLYCAR Post Market Multicenter Study

View source ↗

Summary

GLYCAR's post-market multicenter study update indicates the trial is currently ACTIVE_NOT_RECRUITING. It involves congenital heart disease and peripheral vascul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Peripheral Vascular Disease

Snippet

Sponsor: GLYCAR SA (Pty) Ltd | Conditions: Congenital Premature Cardiac Closure, Cardiac and Great Vessel Reconstruction and Repair | Status: ACTIVE_NOT_RECRUITING